五味消毒饮内服联合天柏金黄散外敷治疗热毒壅盛型亚急性甲状腺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R581.4

基金项目:

佛山市卫生健康局项目(20230390)


Clinical Study on Internal Use of Wuwei Xiaodu Decoction Combined with External Application of Tianbo Jinhuang Powder in Treating Subacute Thyroiditis of Heat Toxity Abundance Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察五味消毒饮内服联合天柏金黄散外敷治疗热毒壅盛型亚急性甲状腺炎(简称亚甲炎) 的临床疗效。方法:选取2022年2月—2024年1月佛山市中医院收治的亚甲炎患者86例,采用随机数字表法 分为对照组和观察组各43例。在治疗过程中,观察组脱落6例,对照组脱落5例,最终共有75例完成研究,其 中对照组38例,观察组37例。对照组予双氯芬酸钠缓释片口服治疗,观察组在对照组基础上加用五味消毒饮 内服和天柏金黄散外敷治疗,2组均治疗2周。比较2组症状消失时间、甲状腺功能指标、甲状腺抗体水平、 炎症因子、氧化应激因子、超声相关指标、疼痛评分、不良反应发生率。结果:观察组甲状腺肿胀消退时间、 颈前疼痛消退时间、体温恢复正常时间均短于对照组(P<0.05)。治疗后,2 组血清游离三碘甲状腺原氨 酸(FT3)、游离甲状腺素(FT4)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)、C-反应蛋 白(CRP)、白细胞介素-6(IL-6)、红细胞沉降率(ESR)、丙二醛(MDA) 水平较治疗前降低,促甲状腺激 素(TSH)、超氧化物歧化酶(SOD) 水平较治疗前升高(P<0.05);且观察组FT3、TPOAb、TGAb、CRP、 IL-6、ESR、MDA水平低于对照组,TSH、SOD水平高于对照组(P<0.05)。治疗后,2组甲状腺动脉峰值流 速、弹性模量较治疗前下降(P<0.05),且观察组甲状腺动脉峰值流速、弹性模量低于对照组(P<0.05)。治 疗后,2组疼痛视觉模拟评分法(VAS) 评分、数字分级评分法(NRS) 评分较治疗前下降(P<0.05),且观 察组VAS评分、NRS评分低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。 结论:五味消毒饮内服联合天柏金黄散外敷治疗热毒炽盛型亚甲炎可有效改善患者的甲状腺功能,降低血清甲 状腺抗体表达,改善甲状腺的大小、血流速度和硬度,促进亚甲炎的恢复,可能与抑制炎症反应和氧化应激反 应有关。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of internal use of Wuwei Xiaodu Decoction combined with external application of Tianbo Jinhuang Powder in treating subacute thyroiditis (SAT) of heat toxin abundance type. Methods: A total of 86 SAT patients admitted to Foshan Hospital of Traditional Chinese Medicine from February 2022 to January 2024 were selected and randomly divided into the control group and the observation group using the random number table method,with 43 cases each. During the treatment period,six cases from the observation group and five from the control group dropped out,resulting in 75 patients completing the study (the control group:38 cases; the observation group: 37 cases). The control group received oral Diclofenac Sodium Sustained-Release Tablets, while the observation group received additional internal use of Wuwei Xiaodu Decoction and external application of Tianbo Jinhuang Powder. Both groups were treated for two weeks. The symptom disappearance time, thyroid function indicators, thyroid antibody levels, inflammatory factors, oxidative stress factors, ultrasound-related indicators, pain scores,and incidence of adverse reactions were compared between the two groups. Results:The disappearance times for thyroid swelling, anterior neck pain, and body temperature normalization in the observation group were shorter than those in the control group (P<0.05). After treatment,serum levels of free triiodothyronine (FT3),free thyroxine( FT4),thyroid peroxidase antibody( TPOAb),thyroglobulin antibody( TGAb),C-reactive protein( CRP), interleukin-6( IL-6),erythrocyte sedimentation rate( ESR),and malondialdehyde( MDA) decreased in both groups, while thyroid-stimulating hormone (TSH) and superoxide dismutase (SOD) levels increased compared to pre-treatment levels (P<0.05). The observation group showed lower levels of FT3, TPOAb, TGAb, CRP, IL-6, ESR, and MDA,and higher levels of TSH and SOD than the control group (P<0.05). After treatment,peak thyroid artery flow velocity and elasticity modulus decreased in both groups (P<0.05),with lower values in the observation group than in the control group( P<0.05). Visual Analogue Scale( VAS) of pain and Numerical Rating Scale( NRS) scores decreased in both groups after treatment (P<0.05), with lower scores in the observation group than in the control group (P< 0.05). No significant differences was found in the incidence of adverse reactions between the two groups (P>0.05). Conclusion:The combination of internal use of Wuwei Xiaodu Decoction and external application of Tianbo Jinhuang Powder effectively improves thyroid function, reduces serum thyroid antibody expression, ameliorates thyroid size, blood flow velocity,and hardness,and promotes recovery in SAT patients,potentially by inhibiting inflammatory and oxidative stress responses.

    参考文献
    相似文献
    引证文献
引用本文

王家乐,魏爱生,叶建红,刘天,张珏,梁佩玲,刘晓霞.五味消毒饮内服联合天柏金黄散外敷治疗热毒壅盛型亚急性甲状腺炎临床研究[J].新中医,2025,57(23):31-37

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-12
  • 出版日期:
文章二维码